These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7239346)

  • 21. Hormone receptors in breast cancer and response to chemotherapy.
    Kiang DT; Kennedy BJ; Frenning DH
    N Engl J Med; 1979 May; 300(18):1053-4. PubMed ID: 431603
    [No Abstract]   [Full Text] [Related]  

  • 22. Hormone receptors in breast cancer and response to chemotherapy.
    Panko WB
    N Engl J Med; 1979 May; 300(18):1053. PubMed ID: 431602
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic strategies in the treatment of breast cancer (author's transl)].
    Huber H; Gattringer C; Grünewald K; Margreiter R; Mikuz G; Frommhold H; Senn HJ; Braunsteiner H
    Wien Klin Wochenschr; 1981 Sep; 93(17):531-41. PubMed ID: 7303699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Status of testing cytostatic drugs in the therapy of malignant tumors].
    Mattern J; Wayss K; Volm M
    Dtsch Med Wochenschr; 1986 Apr; 111(17):676-8. PubMed ID: 3516620
    [No Abstract]   [Full Text] [Related]  

  • 25. Estrogen receptors and response to chemotherapy in advanced breast cancer.
    Cocconi G; De Lisi V; Mori P; Bozzetti C
    Tumori; 1982 Feb; 68(1):67-71. PubMed ID: 7071948
    [No Abstract]   [Full Text] [Related]  

  • 26. The dilemma of estrogen receptors and the response rate to cytotoxic chemotherapy. A problem of comparability analysis.
    Carter SK
    Cancer Clin Trials; 1979; 2(1):49-53. PubMed ID: 519831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High risk breast cancer: long-term surgical adjuvant therapy based on predictive tests - preliminary report.
    Peek U; Tanneberger S; Heise E; Görlich M; Nissen E; Marx G; Projan A; Winkler R; Kunde D; Bodek B
    Arch Geschwulstforsch; 1981; 51(1):139-51. PubMed ID: 7259436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of estrogen receptor data: recommendations for Iowa.
    Corder MP; Caughlan CR; Clark GR; Culp DA; Guthrie RT; Hass AC; Hoak JC; Jochimsen PR; Ketelaar RJ; Leafstedt SW; Maher LL; Wilmarth CB
    J Iowa Med Soc; 1980 Mar; 70(3):105-8. PubMed ID: 7365288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future prospectives in the treatment of breast cancer.
    Henney JE; DeVita VT
    Semin Oncol; 1978 Dec; 5(4):465-8. PubMed ID: 366758
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormone receptors in breast cancer.
    Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():71-2. PubMed ID: 7318873
    [No Abstract]   [Full Text] [Related]  

  • 31. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
    Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.
    Bryce C; Kennecke H; Chia S; Ragaz J
    J Clin Oncol; 2003 Dec; 21(23):4465; author reply 4465-6. PubMed ID: 14645445
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hormones, platinum, and cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):521-2. PubMed ID: 10969202
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent progress in multimodal therapy for resectable breast cancer.
    Bonadonna G
    Isr J Med Sci; 1981; 17(9-10):916-21. PubMed ID: 7309481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Breast cancer: Needs in care and therapy].
    Kaulen H
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():72-3. PubMed ID: 16379248
    [No Abstract]   [Full Text] [Related]  

  • 36. Receptors in the management of breast cancer.
    Hawkins RA
    Br J Hosp Med; 1985 Sep; 34(3):160-4. PubMed ID: 2415195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptors in breast cancer.
    Meredith JT; McBride RC; Cerezo L
    J Fla Med Assoc; 1988 Jan; 75(1):22-8. PubMed ID: 3279159
    [No Abstract]   [Full Text] [Related]  

  • 38. Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
    Voduc D; Nielsen TO
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S171-8. PubMed ID: 19158038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
    Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
    J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.